Latest News about Briefs
Recent news which mentions Briefs
HCA Healthcare Q3 Earnings: Revenue And Profit miss, Sees Hurricane Impact on Q4 and FY25 Earnings Growth
October 25, 2024
From Benzinga
AutoNation's Q3 Stalls: Earnings And Sales Miss Street View As CDK Outage Takes A Toll
October 25, 2024
From Benzinga
Skechers Steps Up Global Game With 16% Q3 Sales Growth, Boosts 2024 Targets With Strong Wholesale & Athlete Appeal
October 25, 2024
From Benzinga
EXCLUSIVE: Avalon GloboCare Inks MoU With Qi Diagnostics For Proposed Co-Development Of Real-Time Cannabis Breathalyzer
October 25, 2024
From Benzinga
Government And Military Contractor Booz Allen Clocks Strong Q2 Performance, Backlog Expands to $41.3B
October 25, 2024
From Benzinga
Colgate-Palmolive Beats Q3 Earnings Amid Market Share Gains And Margin Expansion, Raises 2024 Outlook
October 25, 2024
From Benzinga
Centene Says It Is Positioned To Capture Long-Term Growth In Government-Sponsored Healthcare, Lifts Annual Outlook
October 25, 2024
From Benzinga
Revving Up In The Middle East: Faraday's New UAE Headquarters Solidifies EV Expansion Strategy
October 25, 2024
From Benzinga
Sanofi Earns $5B Q3 Core Profit On Strong Dupixent And Vaccine Sales, Raises 2024 Forecast
October 25, 2024
From Benzinga
Asia Mixed, Europe Up; Dollar Index Steady While Oil Ticks Higher - Global Markets Today While US Slept
October 25, 2024
From Benzinga
Just After Pfizer's RSV Vaccine Approval For Younger Adults, GSK Layouts Encouraging Preliminary Data Showing Potential For Use In Larger Population
October 24, 2024
From Benzinga
Lam Research Positioned For Growth Amid NAND Recovery And Advanced Packaging Strength, Analysts Highlight China Risks
October 24, 2024
From Benzinga
From Benzinga
GE Vernova Gains Investor Confidence With Strong Revenue Outlook And Path To Higher Margins, Say Analysts
October 24, 2024
From Benzinga
CDC And Prevention Advisory Panel Backs Expanded Use Of Pfizer And Merck's Pneumococcal Vaccines
October 24, 2024
From Benzinga
Ozempic Can Potentially Cut Risk Of Alzheimer's Compared To Other Diabetic Medicines, Study Shows
October 24, 2024
From Benzinga
From Benzinga
Apple's AI-Powered Future: iPhone Growth Surge By 2026 With New iPhone 17, AI Integration, Analyst Says
October 24, 2024
From Benzinga
Coca-Cola's Q3 Performance Highlight Resilience Amid Economic Challenges and Strong North American Sales Growth: Analysts
October 24, 2024
From Benzinga
What's Going On With Rivian Automotive Stock Today?
October 24, 2024
From Benzinga
From Benzinga
Visa Teams Up With USAID To Boost Digital Government Platforms In Sub-Saharan Africa And Beyond
October 24, 2024
From Benzinga
Monopar Therapeutics Stock Jumps 4X, Inks Licensing Pact With AstraZeneca For Once Terminated Phase 3 Candidate For Rare Genetic Disorder
October 24, 2024
From Benzinga
S&P Global Q3: Earnings Beat, Boosts 2024 Outlook, Commits To Capital Returns Amid Leadership Shift
October 24, 2024
From Benzinga
West Pharmaceutical's Q3 Performance Shows Rising Demand For Syringes, Company Boosts Annual Forecast And Dividend
October 24, 2024
From Benzinga
Rogers Communications Q3 Earnings Beat Expectations Amid Ongoing Network Investment Plans
October 24, 2024
From Benzinga
From Benzinga
Marinus Pharmaceuticals' Oral Seizure Drug Disappoints In Late-Stage Study, Appoints Advisor To Explore Options
October 24, 2024
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free
Information
Copyright 2024. BUSINESS INSURANCE HOLDINGS
